NeoGenomics Stock Volatility
| NEO Stock | USD 7.96 -0.22 -2.69% |
NeoGenomics shows relatively low price volatility over the last 3 months. The current Sharpe ratio for NeoGenomics is -0.24, reflecting negative risk-adjusted performance over the last 3 months. Current risk dynamics are supported by 24 technical indicators.
Sharpe Ratio = -0.24
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NEO |
NeoGenomics's financial profile includes a Market Risk Adjusted Performance of -1.4%, a Risk of 2.81, and a Risk Adjusted Performance of -0.2%. NeoGenomics is currently underperforming relative to its full potential based on monthly moving average. Adding it to a well-diversified portfolio context can help capture more of its return potential.
Key indicators related to NeoGenomics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Volatility for NeoGenomics measures the dispersion of its stock returns around their average. High-volatility stocks offer greater return potential but require more active risk management.
NeoGenomics | Build portfolio with NeoGenomics Stock |
Volatility Strategy
Volatility in NeoGenomics reflects changing market conditions that influence diversification outcomes. Current statistical measures show total volatility near 2.81% with a beta coefficient of 0.5, indicating sensitivity relative to the broader market benchmark. Risk-adjusted efficiency, represented by a Sharpe ratio of -0.24, evaluates return per unit of total risk. An alpha value of -0.64 reflects performance relative to systematic market exposure. Expected return estimates near -0.68% are derived from historical distribution modeling and help frame forward-looking return assumptions within a portfolio context. Equity volatility may reflect changes in growth expectations.
Main indicators related to NeoGenomics' market risk premium analysis include:
Beta 0.5 | Alpha -0.64 | Risk 2.81 | Sharpe Ratio -0.24 | Expected Return -0.68 |
Moving together with NeoGenomics Stock
| 0.66 | BA | Boeing | PairCorr |
| 0.9 | DIS | Walt Disney | PairCorr |
| 0.67 | BAC | Bank of America | PairCorr |
| 0.64 | JPM | JPMorgan Chase | PairCorr |
| 0.71 | AXP | American Express | PairCorr |
Moving against NeoGenomics Stock
| 0.82 | XOM | Exxon Mobil Corp | PairCorr |
| 0.73 | TRV | The Travelers Companies | PairCorr |
| 0.7 | VZ | Verizon Communications | PairCorr |
| 0.61 | T | ATT Inc | PairCorr |
| 0.57 | JNJ | Johnson Johnson | PairCorr |
| 0.54 | KO | Coca Cola | PairCorr |
| 0.53 | PFE | Pfizer Inc | PairCorr |
| 0.36 | CAT | Caterpillar | PairCorr |
Sensitivity To Market
The beta coefficient of 0.5 for NeoGenomics measures how its returns respond to broader market changes. In regression terms, beta captures the slope between asset returns and index returns. Historical volatility is currently near 2.81%.NeoGenomics return patterns over the selected horizon reflect a minimal level of variability, based on dispersion and downside-focused statistics. Equity volatility often increases when trading volume rises and spreads widen in fast markets.
3 Months Beta |Analyze NeoGenomics Demand TrendCheck current 90 days NeoGenomics correlation with market (Dow Jones Industrial)Downside Risk
Standard deviation of NeoGenomics quantifies daily price dispersion around the mean over your chosen time horizon. A high standard deviation signals high volatility; a low one signals stability.
Standard Deviation | 2.81 |
Understanding the asymmetry between upside and downside risk is critical for investors in NeoGenomics. Standard deviation measures total price dispersion including upside, while downside deviation captures only loss risk in NeoGenomics' returns. NeoGenomics's financial profile includes a Maximum Drawdown of 16.28.
Stock Volatility Analysis
Volatility is a statistical measure of the dispersion of NeoGenomics stock returns over a given period of time. Volatility measures how much NeoGenomics' stock price deviates from its average over a period.
Transformation |
This analysis covers sixty-one data points across the selected time horizon. NeoGenomics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Projected Return Density Against Market
Considering the 90-day investment horizon NeoGenomics has a beta of 0.5003 . This indicates as returns on the market go up, NeoGenomics's average returns are expected to increase less than the benchmark. However, during a bear market, the loss from holding NeoGenomics is expected to be smaller as well.NeoGenomics carries exposure to broad market movements as well as company or sector-specific developments. While portfolio diversification can reduce asset-level risk, systematic volatility cannot be avoided. Standard deviation and beta quantify this exposure. NeoGenomics's financial profile includes a Mean Deviation of 2.12 and a Standard Deviation of 2.81.
Predicted Return Density |
| Returns |
What Drives NeoGenomics' Price Volatility?
Several factors can influence NeoGenomics' market volatility:Industry Dynamics
Sector-level events can directly affect NeoGenomics' price stability. Regulatory changes, supply disruptions, or shifts in demand within NeoGenomics' industry may create volatility even when the broader market is calm. Competitive dynamics and industry consolidation can also amplify price swings for companies like NeoGenomics.Political and Economic Environment
Macroeconomic conditions and policy decisions shape the backdrop for NeoGenomics' price movements. Interest rate changes, trade policy shifts, and fiscal legislation can all alter investor sentiment toward NeoGenomics. During periods of economic expansion, NeoGenomics' price tends to benefit from broader market optimism, while downturns can amplify selling pressure.NeoGenomics' Company-Specific Factors
Volatility can also stem from events unique to NeoGenomics. Earnings surprises, management changes, product launches, or legal developments may trigger sharp price reactions in NeoGenomics' stock. Conversely, operational setbacks, guidance revisions, or data breaches can weigh on NeoGenomics' share price.Stock Risk Measures
Considering the 90-day investment horizon the coefficient of variation of NeoGenomics is -416.67. The daily returns are distributed with a variance of 7.92 and standard deviation of 2.81. The mean deviation of NeoGenomics is currently at 2.12. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.8
α | Alpha over Dow Jones | -0.6361 | |
β | Beta against Dow Jones | 0.50 | |
σ | Overall volatility | 2.81 | |
Ir | Information ratio | -0.2086 |
Stock Return Volatility
Volatility for NeoGenomics quantifies the day-to-day dispersion of stock returns around their historical average. The firm carries 2.8136% return volatility across the 90-day horizon. As a benchmark, Dow Jones Industrial has volatility of 0.8181% on return distribution over a 90-day investment horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
NeoGenomics Company may look attractive on headline returns alone, but deeper analysis often tells a different story. A thorough review of NeoGenomics' risk-adjusted indicators provides a clearer picture of whether returns are being earned efficiently. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XGN | 3.06 | -1.40 | 0.00 | 1.80 | 0.00 | 4.28 | 18.81 | |||
| MDXH | 2.49 | -0.06 | 0.00 | -0.61 | 0.00 | 5.25 | 17.05 | |||
| STXS | 2.41 | -0.43 | 0.00 | -1.22 | 0.00 | 4.52 | 14.48 | |||
| ACRS | 4.29 | 0.62 | 0.15 | -2.05 | 4.42 | 6.27 | 84.20 | |||
| QTRX | 3.14 | -0.60 | 0.00 | -1.52 | 0.00 | 6.84 | 34.06 | |||
| SGMT | 2.98 | -0.39 | 0.00 | 0.59 | 0.00 | 5.78 | 22.02 | |||
| SMTI | 2.27 | -0.53 | 0.00 | 0.73 | 0.00 | 4.69 | 14.97 | |||
| ARCT | 2.48 | 0.05 | 0.05 | -2.35 | 2.88 | 6.13 | 17.23 | |||
| HUMA | 4.91 | 0.06 | 0.00 | -0.08 | 0.00 | 11.11 | 49.60 | |||
| TKNO | 3.58 | -0.60 | 0.00 | -2.34 | 0.00 | 7.89 | 26.02 |
Risk Metrics, Assumptions & Methodology
Volatility for NeoGenomics measures return dispersion and uncertainty over time. Standard deviation provides a baseline measure of variability magnitude. NeoGenomics has a market cap of 1.03 B, P/E of 272.37, ROE of -12.43%.
This section for NeoGenomics is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. Volatility and downside metrics are estimated from historical return dispersion.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardNeoGenomics Investment Opportunity
NeoGenomics is about 3.43 times more volatile than Dow Jones Industrial based on recent return behavior. Across the current 90-day horizon, that places the security below 25% of the broader equity and portfolio universe on a pure volatility basis.You can use NeoGenomics to protect the portfolio against small market fluctuations. This directional read frames the latest price swing through a simple momentum and follow-through lens. It works best as a directional cue rather than as a standalone forecast. an unexpected downward movement. The market is reacting to new fundamentals. Check odds of NeoGenomics to be traded at $7.64 in 90 days.Poor diversification
For the present investment horizon, the measured correlation between NeoGenomics and Dow Jones stands at 0.64, or Poor diversification. Lower overlap tends to improve diversification, while higher overlap means both positions carry similar risk.
NeoGenomics Additional Risk Indicators
Risk analysis around NeoGenomics becomes more useful when investors review secondary indicators that can confirm, refine, or challenge the basic volatility picture. Used correctly, these measures can support both standalone risk assessment and portfolio-level hedging decisions.
| Risk Adjusted Performance | -0.19 | |||
| Market Risk Adjusted Performance | -1.36 | |||
| Mean Deviation | 2.12 | |||
| Coefficient Of Variation | -416.67 | |||
| Standard Deviation | 2.81 | |||
| Variance | 7.92 | |||
| Information Ratio | -0.21 |
NeoGenomics Suggested Diversification Pairs
Pair analysis around NeoGenomics matters because it can turn one security idea into a more market-neutral structure. Used properly, pair trading is less about prediction in isolation and more about identifying relative mispricing between related positions.
Risk reduction through pair trading is real but has limits - not every type of exposure can be offset by a second leg. NeoGenomics' exposure to overall market risk stays intact regardless of pairing. The value of a second leg lies in reducing NeoGenomics' idiosyncratic risk - the part that comes from company-level events rather than macro conditions.